関連する実験動画
Updated: Feb 24, 2026

08:00
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
14.3K
Hematopoietic stem cell aging promotes TET2 clonal hematopoiesis
Research square
|February 23, 2026
まとめ
Aging accelerates clonal hematopoiesis (CH) by reducing the fitness of normal hematopoietic stem cells (HSC). Tet2 inactivation abrogates aging-associated changes, promoting CH development.
科学分野:
- 血液学
- 老化研究
- がん生物学
背景:
- 老化はクローン性造血(CH)および骨髄悪性腫瘍と関連しています。
- CH変異のクローン選択に対する老化の影響は不明なままです。
研究 の 目的:
- CH変異を持つ造血幹細胞(HSC)のクローン性増殖における老化の役割を調査すること。
- 老化がCHを促進するメカニズムを解明すること。
主な方法:
- Tet2ノックアウト(KO)造血幹細胞(HSC)を用いたCHのマウスモデルを利用しました。
- 様々な年齢のレシピエントにおいて、古いドナーマウスと若いドナーマウス由来のHSCの増殖率を比較しました。
- マウスとヒトの両方の老化および若いHSCにおける遺伝子発現パターンと細胞応答を分析しました。
主要な成果:
- 移植された古いドナー由来のTet2 KO HSCは、レシピエントの年齢に関係なく、若いHSCよりも速く増殖しました。
- この加速された増殖は中年までに明らかになり、老化コンペティターの突然変異のないHSCのフィットネスの低下に起因すると考えられました。
- 老化HSCはRUNX1活性とリボソームタンパク質遺伝子発現の増加を示し、p53媒介ストレス応答を引き起こしましたが、これはTet2/TET2不活性化によって逆転しました。
結論:
- 老化は、Tet2、Runx1、およびTrp53変異HSCのクローン性増殖を促進する環境を作り出します。
- このプロセスは、クローン性造血および潜在的な骨髄悪性腫瘍の発症を促進します。
関連する概念動画
Multipotency of Hematopoietic Stem Cells
4.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.0K
Regulation of Hematopoietic Stem Cells
4.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.2K
Hematopoiesis
9.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.3K
Replicative Cell Senescence
4.5K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.5K
Lineage Commitment
4.5K
Commitment is the process whereby stem cells:
4.5K
Stem Cell Therapy for Tissue Regeneration
4.7K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.7K

